Bristol-Myers seeks alternatives to aid its drug pipeline
Bristol-Myers Squibb co. has asked New York investment bank goldman Sachs Group Inc. to explore a host of alternative strategies that might help remedy that pharmaceutical concern's looming
Bristol-Myers Squibb co. has asked New York investment bank goldman Sachs Group Inc. to explore a host of alternative strategies that might help remedy that pharmaceutical concern's looming